EARNING RECAP

Fedex

#FDX 2019 EPS:(Actual vs Estimate) Revenue(Actual vs Estimate) Stock price move next bell High Low Notes
Q3 $3.03 est. $3.11 $17B est. $17.67B -3.49% ($175.07 closing price0 $175.77 $169.66 CUTS FY19 EPS view to $15.10-$15.90 from $15.50- $16.50
Q2 adjusted $4.03 est. $3.94 $17.8B est. $17.75B -12.16% ($162.51 closing price) $171.63 $162.50 stocks hits 52 weeks low; Fy19 cut guidance to $15.5- $16.50 from $17.20-$17.80 est. $17.33, cites weakness induced by wrong Political choices, cites slowdown in China & EU
Q1 adjusted $3.46 est. $3.82 $17.1B est. $16.88B -5.53% ($241.58 closing) $250 $241.22 raises FY19 EPS view to $17.20 -$17.80 from $17- $17.60 est. $17.33; CAPEX $5.6B
#FDX 2018 EPS:(Actual vs Estimate) Revenue(Actual vs Estimate) Stock price move next bell High Low Notes
Q4 adjusted $5.91 est. $5.68 $17.3B est. $17.24B -2.69% ($251.43 closing) $257.31 $251.09 sees FY19 CAPEX at $5.6B; sees FY19 EPS $17-$17.60 est. $17.42;sees FY19 Operating margin at 8.5% vs: 7.8% last year
Q3 $3.72 est. $3.11 $16.5B est. $16.15B -1.18% ($249.02) $258 $249.01 Fedex says revenue growth driven by international business; Tax reform will be offset by taxes due to tariff*
Q2 adjusted EPS $3.18 est. $2.89 $16.3B est. $15.68B +3.52% 253.24 246.60 sees U.S. GDP growth 2.5% in 2018 & Global GDP growth at 3% 2017 & 2018*
Q1 adjusted EPS $2.51 est. $3.09 $15.3B est. $15.35B +2.08% (*$220.5 closing price*) 222.71 215.57 Record high

Please select phase first
Disclaimer! This is NOT an investment advice. The data result herein is purely speculation only. You must do your own due diligence and mitigate your risk. You acknowledge that TradersFish.com will not be held responsible and accountable for any losses you may incur using our Biotech Data Calculator. Please consult your own financial adviser before executing trades.